Spectral Medical【EDT】銘柄情報

Spectral Medical Inc (EDT) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.36

( - )

買値

1.36

売値

1.37

出来高

40,600

1.35 日の範囲 1.39

0.77 52 週間の範囲 1.84

時価総額

399.05M

前日終値

1.36

始値

1.37

時刻

100

1.36

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

$ 56,820

発行済株式数

293,418,991

配当利回り

PER

-10.5

1 株当たり利益 (EPS)

-0.13

歳入

2.76M

純利益

-38.03M

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gr... Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada. 詳細を表示

セクター

Healthcare

業界

Medical Diagnostics & Screening

ウェブサイト

spectraldx.com

本社

Toronto, Canada

設立

1991

Spectral Medical Inc is listed in the Healthcare sector of the トロント証券取引所 with ticker EDT. The last closing price for Spectral Medical was $1.36. Over the last year, Spectral Medical shares have traded in a share price range of $ 0.77 to $ 1.84.

Spectral Medical currently has 293,418,991 shares in issue. The market capitalisation of Spectral Medical is $399.05 million. Spectral Medical has a price to earnings ratio (PE ratio) of -10.50.

Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a...

Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial

100% follow-up achieved for all 157 patients enrolled in the Tigris trialMortality at 12 months was 52.8% with...

Spectral Medical Announces PMA Submission to U.S. FDA for PMX

TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a...

Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update

PMA submission targeted for May 29, 2026 in alignment with FDAVantive commits to additional funding support...

Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update

TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a...

Spectral Medical and Vantive Announce Publication of Complete Results from Spectral’s Tigris Trial in the Lancet Respiratory Medicine

Tigris publication confirms positive results for primary and key secondary endpoints with 95.3% and 99.4...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	1.36	1.4	1.35	28932	1.3745646	CS
4	-0.05	-3.54609929078	1.41	1.45	1.34	46183	1.39106647	CS
12	-0.02	-1.44927536232	1.38	1.47	1.32	47333	1.38677593	CS
26	0.09	7.08661417323	1.27	1.52	1.21	53173	1.36934792	CS
52	0.51	60	0.85	1.84	0.77	87962	1.29718759	CS
156	1.09	403.703703704	0.27	1.84	0.26	73933	0.8452538	CS
260	0.905	198.901098901	0.455	1.84	0.15	76431	0.63469152	CS